About
CO.DON is science-driven biopharmaceutical company committed to research, development and commercialisation of autologous cell therapies for the repair of cartilage defects. Our products use only the patientÕs own cells and blood, is additive-free and the procedure is minimally invasive.
Currently, over 11,000 patients have been treated in 200 clinics in Germany.
In July 2017 we received marketing authorisation for an advanced therapy medicinal product from the European Medicine Agency.
CO.DON is listed on the Frankfurt Stock Exchange. (ISIN: DE000A1K0227).
- Company Name:Co.don Ag
(View Trends)
-
Headquarters: (View Map)Teltow, Germany
-
Biotechnology
-
50 - 200 employees
Site Traffic
- 4557672 Global Rank
- 650729 Germany
Traffic Sources
-
Search49.95%
-
Direct40.21%
-
Referrals9.83%
-
Display0.00%
-
Mail0.00%
-
Social0.00%
Powered by
![]()
Alexa Traffic Data
Global Rank
1,185,707
269
Links In Count
27
69
United States Rank
8,142
2,389
United States Page Views
69.9%
10.8%
Top Countries
- United States 69.9%
- India 11.6%
- Pakistan 3.1%
- Israel 0.9%
- Turkey 0.8%
Top Sites Linking In
Top Search Keywords
- Deutsch
- Pharma und Biotechnologie
They are headquartered at Teltow, Germany, and have 2 advertising & marketing contacts listed on Kochava. Co.don Ag works with Advertising technology companies such as DoubleClick.Net.
